Monitoring oral anticoagulant treatment with the TAS near-patient test system: Comparison with conventional thromboplastins

Journal of Clinical Pathology

Volumn 50, Issue 11, 1997, Pages 951-956

  Kitchen, S ^a   Preston, F E ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

INR; Near patient testing; Prothrombin time; Thrombolytic Assessment System

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PROTHROMBIN; THROMBOPLASTIN; WARFARIN;

ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INSTRUMENT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOEMBOLISM;

EID: 0030783773     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.11.951     Document Type: Article

References (21)

1. Dalen JE, Hirsh J. American College of Chest Physicians and National Heart Lung and Blood Institute national conference on antithrombotic therapy. Arch Intern Med 1986;146:462-72.
2. Loeliger LA, van den Besselaar AMHP, Broekmans AW. Intensity of oral anticoagulation in patients monitored with various thromboplastins. N Engl J Med 1983;308:1228-9.
3. Denson KWE. Thromboplastin sensitivity, precision and other characteristics. Clin Lab Haem 1988;10:315-28.
4. Loeliger EA, van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the normalisation of the prothrombin times on oral anticoagulant control. Thromb Haemost 1985;53:148-54.
5. Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrak 512 coagulation monitor for the control of oral anticoagulant therapy. J Clin Pathol 1991;44:950-3.
6. Yano Y, Kambayasni J, Murata K, Shiba E, Saron M, Kawasaki T, et al. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Research 1992;66:583-90.
7. Rose VI, Dermott SC, Murray BF, Melver MM, Higt KA, Oberhardt BJ. Decentralised testing for prothrombin time and activated partial thromboplastin time using a dry-chemistry portable analyser. Arch Pathol Lab Med 1993; 117:611-17.
8. Tripodi A, Arbin AA, Chantarangkul V, Bettega O, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control or oral anticoagulant treatment by the International Normalised Ratio? Thromb Haemostas 1993;70:921-4.
9. White RH, Becker DM, Gunther-Mäher. Outpatient use of a portable International Ratio/prothrombin time monitor. South Med J 1994;87:206-10.
10. Foulis PR, Wallach PM, Adelman HM, Sanford BH, McCain J, Reed D, et al. Performance of the Coumatrak system in a large anticoagulant clinic. Am J Clin Pathol 1995;103:98-102.
11. Oberhadt BJ, Dermott SC, Taylor M, Alkadi XY, Abruzzini A, Gresalhi NJ. Dry reagent technology tor rapid convenient measurements of blood coagulation and fibrinolysis. Clin Chem 1991;37:520-6.
12. WHO Expert Committee on Biological Standardisation. 33rd report. WHO Technical Report Series 1983;687: 81-105.
13. Thomson JM, Parby KV, Poller L. Calibration of BCT/441. The ICSH reference preparation for thromboplastin 1986;55: 379-82.
14. Donnachie D, Kitchen S, Preston FE. Evaluation of a clotting anti-Xa assay for heparin. Br J Haematol 1994;86:33.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical assessment. Lancet 1986;i:307-10.
16. Tomenson JA, Thomson JM. Standardisation of the prothrombin time. In: Thomson JM, ed. Blood coagulation and haemostasis. Edinburgh: Churchill Livingstone, 1985: 370-409.
17. Hirsh J, Levine M. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America. Thromb Haemost 1988;59:129-32.
18. Bussey HI, Force FW, Bianco TM, Leonard AD. Reliance on prothrombin time ratio causes significant error in anticoagulation therapy. Arch Intern Med 1992; 152:278-82.
19. Ansell JD. Imprecision of prothrombin time monitoring of oral anticoagulation: a survey of hospital laboratories. Am J Clin Pathol 1992;98:237-9.
20. Kitchen S, Walker ID, Woods TAL, Preston FE. Thromboplastin related differences in the determination of International Normalised Ratio. Thromb Haemost 1994;72: 426-9.
21. Kitchen S, Jennings I, Woods TAL, Walker ID, Preston FE. Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of International Normalised Ratio: a 33 laboratory collaborative study. Thromb Haemost 1996;76:372-6.